COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,833 Articles (22,553 medRxiv, 8,280 bioRxiv)

Most recent first Previous |  Page 845: Articles 8441-8450  | Next

Three separate spike antigen exposures by COVID-19 vaccination or SARS-CoV-2 infection elicit strong humoral immune responses in healthcare workers
Brehm, T. T., Ullrich, F., Thompson, M., Kuechen, J., Schwinge, D., Spier, A., Huber, S., Knobloch, J. K., Aepfelbacher, M., Addo, M. M., Lohse, A. W., Luetgehetmann, M., Schulze zur Wiesch, J.
10.1101/2022.03.06.22271718 — Posted: 2022-03-08
"Pandemic of the unvaccinated"? At midlife, white people are less vaccinated but still at less risk of Covid-19 mortality in Minnesota
Wrigley-Field, E., Berry, K. M., Stokes, A. C., Leider, J. P.
10.1101/2022.03.02.22271808 — Posted: 2022-03-08
Post COVID-19 Condition in South Africa: 3-month follow-up after hospitalisation with SARS-CoV-2
Dryden, M., Mudara, C., Vika, C., Blumberg, L., Mayet, N., Cohen, C., Tempia, S., Parker, A., Nel, J., Perumal, R., Groome, M., Conradie, F., Ndjeka, N., Sigfrid, L., Merson, L., Jassat, W.
10.1101/2022.03.06.22270594 — Posted: 2022-03-08
Risk of myocarditis and pericarditis following COVID-19 vaccination in England and Wales
Ip, S., Torabi, F., Denaxas, S., Akbari, A., Abbasizanjani, H., Knight, R., Cooper, J. A., Denholm, R., Keene, S., Bolton, T., Hollings, S., Omigi, E., North, T.-L., Karthikeyan Suseeladevi, A., Di Angelantonio, E., Khunti, K., Sterne, J. A. C., Sudlow, C., Whiteley, W., Wood, A., Walker, V., British Heart Foundation Data Science Centre (HDR UK) CVD-COVID-UK/COVID-IMPACT Consortium, , UK Covid-19 Longitudinal Health and Wellbeing National Core Study, , UK Covid-19 Data and Connectivity National Core Study
10.1101/2022.03.06.21267462 — Posted: 2022-03-08
High frequency and persistence of Anti-DSG2 antibodies in post COVID-19 serum samples
Lee, E., Tyler, R. E., Johnson, D., Koh, N., Ong, B. C., Foo, S. Y., Tan, J.
10.1101/2022.02.23.22271045 — Posted: 2022-03-08
The relative impact of vaccination momentum on COVID-19 rates of death in the USA in 2020/2021. The forgotten role of population wellness.
Keddis, V.
10.1101/2022.03.01.22271721 — Posted: 2022-03-08
Geneticin shows selective antiviral activity against SARS-CoV-2 by targeting programmed -1 ribosomal frameshifting
Varricchio, C., Mathez, G., Kaiser, L., Tapparel, C., Brancale, A., Cagno, V.
10.1101/2022.03.08.483429 — Posted: 2022-03-08
The origins and molecular evolution of SARS-CoV-2 lineage B.1.1.7 in the UK
Hill, V., du Plessis, L., Peacock, T. P. A., Aggarwal, D., Carabelli, A., Colquhoun, R., Ellaby, N., Gallagher, E., Groves, N., Jackson, B., McCrone, J., O'Toole, A. N., Price, A., Sanderson, T., Scher, E., Southgate, J. A., Volz, E., The COVID-19 genomics UK (COG-UK) consortium, , Barclay, W. S., Barrett, J., Chand, M., Connor, T. R., Goodfellow, I. G., Gupta, R. K., Harrison, E., Loman, N., Myers, R., Robertson, D. L., Pybus, O., Rambaut, A.
10.1101/2022.03.08.481609 — Posted: 2022-03-08
Anti-spike antibody response to natural infection with SARS-CoV-2 and its activity against emerging variants
Chen, C.-P., Huang, K.-Y. A., Shih, S.-R., Lin, Y.-C., Cheng, C.-Y., Huang, Y.-C., Lin, T.-Y., Cheng, S.-H.
10.1101/2022.03.07.481737 — Posted: 2022-03-08
Patients at risk of pulmonary fibrosis Post Covid-19: Epidemiology, pulmonary sequelaes and humoral response
Hernandez Porto, M., Delgado, T., Aguirre-Jaime, A., Ramos, M. J., Campos, S., Acosta, O., LLanos, A. B., Lecuona, M.
10.1101/2022.03.04.22271920 — Posted: 2022-03-07

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).